Evaluation of Aesculap Implant Systems activl Artificial Disc for the treatment of degenerative disc disease.

about

We Need to Talk about Lumbar Total Disc Replacement

P2860

Q57135664-A893D587-1FDF-444D-8A3B-F839B779BD56

P2860

Evaluation of Aesculap Implant Systems activl Artificial Disc for the treatment of degenerative disc disease.

Item

http://www.wikidata.org/entity/Q38799736

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evaluation of Aesculap Implant ...... of degenerative disc disease.

@en

type

Item

label

Evaluation of Aesculap Implant ...... of degenerative disc disease.

@en

prefLabel

Evaluation of Aesculap Implant ...... of degenerative disc disease.

@en

P1476

Evaluation of Aesculap Implant ...... of degenerative disc disease.

@en

P2093

Daniel Shein

http://www.w3.org/2001/XMLSchema#string

Federico Girardi

http://www.w3.org/2001/XMLSchema#string

Jennifer Shue

http://www.w3.org/2001/XMLSchema#string

P2860

Charité total disc replacement--clinical and radiographical results after an average follow-up of 17 years

Clinical and radiological outcomes with the Charité artificial disc: a 10-year minimum follow-up

Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective long-term study comparing fusion and pseudarthrosis.

Total disc replacement compared to lumbar fusion: a randomised controlled trial with 2-year follow-up

Total disc replacement surgery for symptomatic degenerative lumbar disc disease: a systematic review of the literature.

Adjacent segment degeneration and adjacent segment disease: the consequences of spinal fusion?

Complications and surgical revision for failed disc arthroplasty.

Comparison of artificial total disc replacement versus fusion for lumbar degenerative disc disease: a meta-analysis of randomized controlled trials

Lumbar Total Disc Replacement for Discogenic Low Back Pain: Two-year Outcomes of the activL Multicenter Randomized Controlled IDE Clinical Trial.

Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.

P304

1069-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17434440.2016.1256771

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27807981

http://www.w3.org/2001/XMLSchema#string

Evaluation of Aesculap Implant Systems activl Artificial Disc for the treatment of degenerative disc disease.

about

P2860

P2860

Evaluation of Aesculap Implant Systems activl Artificial Disc for the treatment of degenerative disc disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698